Covax Signs Deal For 500 Million Moderna Covid Vaccine Doses

"We are very pleased to sign this new agreement with Moderna, giving Covax facility participants access to yet another highly efficacious vaccine," chief executive of the Gavi vaccine alliance said.

The Covax global vaccine equity programme said Monday it has struck a deal to buy 500 million doses of Moderna's Covid-19 jabs. The doses, to come on stream from October at the earliest, will broaden out the portfolio of vaccines in the Covax scheme, which has so far been heavily reliant on the AstraZeneca vaccine and hit by delays. The Moderna doses are expected to start supplying Covax in the final quarter of 2021, with 34 million doses available before the end of the year, the Covax scheme's co-leader Gavi announced in a statement. A further 466 million doses will follow in 2022.